ASSET | DATE | % RETURN |
---|---|---|
Indivior PLC Ordinary Shares (INDV) | 10/3/2022 - 11/8/2022 | 562% |
Biohaven Pharmaceutical (BHVN) | 10/3/2022 - 11/8/2022 | 143.66% |
Spyre Therapeutics (SYRE) | 10/3/2022 - 11/8/2022 | 138.68% |
Tango Therapeutics (TNGX) | 10/3/2022 - 11/8/2022 | 109.19% |
Enliven Therapeutics (ELVN) | 10/3/2022 - 11/8/2022 | 104.33% |
SS Innovations International Inc Common Stock (SSII) | 10/3/2022 - 11/8/2022 | 84.09% |
Compass Therapeutics (CMPX) | 10/3/2022 - 11/8/2022 | 80.08% |
Arqit Quantum (ARQQ) | 10/3/2022 - 11/8/2022 | 80% |
Oil States International (OIS) | 10/3/2022 - 11/8/2022 | 72.44% |
Helix Energy Solutions (HLX) | 10/3/2022 - 11/8/2022 | 68.3% |
Enviri (NVRI) | 10/3/2022 - 11/8/2022 | 67.89% |
ADEIA (ADEA) | 10/3/2022 - 11/8/2022 | 67.22% |
Nabors Industries (NBR) | 10/3/2022 - 11/8/2022 | 64.26% |
Lindblad Expeditions (LIND) | 10/3/2022 - 11/8/2022 | 60.95% |
Riley Exploration Permian (REPX) | 10/3/2022 - 11/8/2022 | 60.75% |
MediaAlpha (MAX) | 10/3/2022 - 11/8/2022 | 57.43% |
Precision Drilling (PDS) | 10/3/2022 - 11/8/2022 | 56.2% |
Onity (ONIT) | 10/3/2022 - 11/8/2022 | 56.11% |
OneSpan (OSPN) | 10/3/2022 - 11/8/2022 | 55.4% |
ProFrac (ACDC) | 10/3/2022 - 11/8/2022 | 55.35% |
Greenbrier Companies (GBX) | 10/3/2022 - 11/8/2022 | 54.22% |
Pacific Biosciences of California (PACB) | 10/3/2022 - 11/8/2022 | 53.05% |
Arcturus Therapeutics (ARCT) | 10/3/2022 - 11/8/2022 | 51.83% |
Advantage Solutions (ADV) | 10/3/2022 - 11/8/2022 | 51.63% |
Aehr Test Systems (AEHR) | 10/3/2022 - 11/8/2022 | 51.26% |